Feedback
Full Name :  
Company :  
E-mail :  
Phone Number :  
Comments :  
   
   
 
EnColl Corporation
 
 
DERMAL / DENTAL
 
  Currently
US-FDA cleared
HELICOLL
US FDA K#040314
 
 
 
CARDIOVASCULAR / ORTHOPEDIC
 
 
STEMCELL AND GENE THERAPY
 
 
Click here
 
 
SKINCARE / NUTRITIONAL / VET.
 
EnColl has developed a DNA-infused gel of modified collagen (CollatrixTM) for use as a delivery matrix in gene therapy. In addition to gene delivery, more products would require CollatrixTM for the delivery of cytokines like growth factors and certain drugs like insulin as well as anti-microbial agents. This collagen based matrix has greater biocompatibility and bioactivity than other available products.
 
Home  I  Corporate Info  I  Our Products  I  Place an Order  I  Research  I  Contact Us All Rights Reserved EnColl @ 2013